Medical Device News Magazine

Noninvasix Appoints David J. Giarracco as CEO

Seasoned Medtech Executive Will Advance Commercialization of Non-invasive Monitoring System to Identify Sepsis as Early as Possible

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...


  • Giarracco combines this expertise with start-up experience as chief operations officer at SeaStar Medical and as a lead investor and board member at early-stage healthcare technology companies.

Noninvasix reported today that David J. Giarracco has been appointed the new CEO of the company. A veteran medical device executive with relevant critical care market experience, Giarracco will advance the commercialization of the only non-invasive patient monitoring device designed for earlier detection of life-threatening sepsis so it can be treated to improve patient outcomes.

Dave is the right leader at the right time for Noninvasix,” said Tom Luby, Ph.D., Director of Texas Medical Center Innovation Venture Fund. “He has a deep understanding of launching new platform technologies that make a critical difference in patient safety and clinical outcomes while reducing overall healthcare costs.”

Giarracco has extensive experience in the launch and global commercialization of novel patient-monitoring technologies in both hospital and home care settings. In leadership roles at Medtronic and Covidien, he successfully scaled organizations to exceed business plans by strategically developing markets, addressing commercial structure, and creating clinically focused, solution-selling organizations. Giarracco combines this expertise with start-up experience as chief operations officer at SeaStar Medical and as a lead investor and board member at early-stage healthcare technology companies.

“Dave will play an essential role in helping refine our strategy and drive product development activity to realize our mission of better detecting and monitoring sepsis,” said Dr. Donald Prough, Rebecca Terry White Distinguished Professor and Chairman of the Department of Anesthesia at the University of Texas Medical Branch. “As a Noninvasix founder and practicing anesthesiologist, I am excited about our future and the opportunity to make a significant impact on this major healthcare challenge.”

“Prevention and control strategies for sepsis infections are urgently needed,” said Giarracco. “We need new, non-invasive approaches for early diagnosis to reduce complications and save lives. Noninvasix technology promises to make a major difference in patient care, reduce healthcare costs and have wider applications beyond sepsis.”

Giarracco received his Bachelor of Science in Biomedical Engineering from The Johns Hopkins University and his Master of Arts in Biomedical Engineering from The Johns Hopkins School of Medicine. He brings more than 25 years of medical technology experience as an engineer, commercial leader, and early-stage investor in innovative, category-defining technologies.


Medical Device News Magazine
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in Suspected Coronary Artery Disease

The HeartFlow Plaque Analysis uses proprietary algorithms to analyze coronary CT angiogram (CCTA) scans, creating a personalized 3D model that quantifies and characterizes plaque volume in the coronary arteries, aiding risk assessment of coronary artery disease. The technology was introduced at the Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting in Washington, D.C.

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

Recognizing each individual’s health journey is unique, PowerPlugs enable people to choose and focus on the aspects of their health that matter most. It’s designed for highly personalized health insights, ensuring that every individual can personalize their health tracking to their unique needs and goals.

VisionAir Solutions Celebrates Milestone and New Collaboration

This achievement marks VisionAir Solutions commitment to bringing technological innovation to pulmonary medicine. Since its acquisition by Theken Companies last year, VAS has over doubled its growth and continues to demonstrate industry adoption and the advantages of personalized healthcare.